GS-5806
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GS-5806, covering 2013-10-28 to 2015-08-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) [Phase 2]